About VieCure
VieCure is a company based in Greenwood Village (United States) founded in 2015 by Fred Ashbury. VieCure has raised $113 million across 3 funding rounds from investors including Northpond Ventures, Durable Capital Partners and Socium Ventures. VieCure offers products and services including VieCure Platform and Halo Intelligence Platform. VieCure operates in a competitive market with competitors including Syapse, BostonGene, Melatech, Kuveda and Cystotech ApS, among others.
- Headquarter Greenwood Village, United States
- Founders Fred Ashbury
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$113 M (USD)
in 3 rounds
-
Latest Funding Round
$43 M (USD), Series C
Jan 12, 2026
-
Investors
Northpond Ventures
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VieCure
VieCure offers a comprehensive portfolio of products and services, including VieCure Platform and Halo Intelligence Platform.
Platform for personalizing cancer care with AI tools.
System for advanced cancer care insights and data processing.
People of VieCure
Unlock access to complete
Funding Insights of VieCure
VieCure has successfully raised a total of $113M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $43 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in VieCure
VieCure has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Northpond Ventures, Durable Capital Partners and Socium Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life sciences & tech sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for VieCure
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VieCure
Investment portfolio details for VieCure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VieCure
Detailed financials for VieCure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Viecure Comparisons
Peer comparison for VieCure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VieCure
VieCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syapse, BostonGene, Melatech, Kuveda and Cystotech ApS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of precision medicine for the treatment of cancer
|
|
| Locked | Locked | Locked |
Developer of cloud-based information and analytics platform to treat cancer
|
|
| Locked | Locked | Locked |
AI-based patient treatment management tool for providers
|
|
| Locked | Locked | Locked |
SaaS tools for analyzing cancer patients' molecular profiles are provided.
|
|
| Locked | Locked | Locked |
Delivers AI-based decision support solutions for bladder cancer treatment.
|
Detailed competitors of VieCure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Viecure
Complete news archive for VieCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VieCure
VieCure was founded in 2015 and raised its 1st funding round 6 years after it was founded.
VieCure is headquartered in Greenwood Village, United States. It is registered at Greenwood Village, Colorado, United States.
VieCure is a funded company, having raised a total of $113M across 3 funding rounds to date.
Founded in 2015 and based in Greenwood Village, United States, VieCure operates in the oncology sector through an AI platform. Patient-specific treatment plans are created for oncologists, supported by an electronic medical record system that tracks medical history, treatment progress, notes, prescriptions, medication administration, scheduling, and pharmacy services. A mobile application is provided for patient engagement, including treatment adherence, side effect monitoring, and communication with the oncology team.
VieCure's top competitors include Syapse, BostonGene and Melatech.
VieCure offers VieCure Platform and Halo Intelligence Platform.
VieCure has 4 investors. Key investors include Northpond Ventures, Durable Capital Partners, Socium Ventures, and Sator Grove Holdings.